SynthesisBioscience reports2026

A systematic review and meta-analysis of shRNA-IL-6-engineered CAR-T cells for B-cell acute lymphoblastic leukemia: a stepping stone toward risk-free immunotherapy.

Mohamed S Attia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.